WebStockholders' equity is comprised of several components; capital, retained earnings, dividends and treasury stock. CYTO 1.84 +0.21(12.88%) Will CYTO be a Portfolio Killer in April? WebEarnings for Altamira Therapeutics (CYTO) Earnings in 2024 (TTM): -$11.57 M According to Altamira Therapeutics 's latest financial reports the company's current earnings (TTM) are -$11.57 M .
What is the current Price Target and Forecast for Altamira …
WebCompany’s earnings for a period net of operating costs, taxes, and interest. -3.65M. -8.17%. Net profit margin. Measures how much net income or profit is generated as a percentage of revenue ... WebAltamira Therapeutics (CYTO) will release its next earnings report on Aug 17, 2024. In the last quarter Altamira Therapeutics reported ― EPS in relation to ― expected by the market. elderly man dragged by youth
Altamira Therapeutics Ltd. (CYTO) - Yahoo Finance
WebNov 30, 2024 · Altamira Therapeutics (CYTO) reports earnings on 11/30/2024. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. … WebApr 13, 2024 · Altamira Therapeutics ( NASDAQ:CYTO – Get Rating) and Viracta Therapeutics ( NASDAQ:VIRX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, … WebFind the latest Earnings Report Date for Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) (CYTO) at Nasdaq.com. food in pregnancy an ayurvedic overview